Omega-3 Evidence by Use: Heart, Triglycerides, Pregnancy, Brain and Eyes
Omega-3 evidence by use: what reviews and major trials found for heart disease, triglycerides, pregnancy, brain, depression, eyes and arthritis, and how prescription medicines differ.
Content last updated . This page has not been medically reviewed.
Overview
"Does omega-3 work?" depends on the outcome, the person and the product. This page sorts the main uses into a table with the study type and strength. Evidence labels: established, evidence in adequately nourished people, promising but limited, mixed, insufficient evidence. All amounts are study amounts, not recommendations. Product guides: fish oil, algal oil, flaxseed oil.Supplements are not the same as prescription medicines
Several omega-3 products are approved drugs. Vascepa (purified EPA ethyl ester) is approved at 4 g a day for specific groups: with a statin to lower cardiovascular risk in people with high triglycerides and heart disease or diabetes plus risk factors, and with diet for severe hypertriglyceridemia (500 mg/dL or higher). [1] Lovaza (EPA and DHA ethyl esters) is approved for severe hypertriglyceridemia and its label says its effect on cardiovascular events has not been determined. [2] NCCIH notes that prescription products differ in composition, testing and regulation from supplements, so their effects may not apply to supplements. [3] See Prescription omega-3 vs supplements.Evidence table
| Use | What the sources found | Label |
|---|---|---|
| Preventing heart disease in the general population | VITAL, 25,871 adults, 1 g a day: no significant drop in major cardiovascular events; Cochrane: little or no effect on all-cause death or cardiovascular events [4][5] | Evidence in adequately nourished people: no clear benefit |
| Coronary events and death | Cochrane: possible slight reduction (risk ratio 0.90 and 0.91; low certainty) [5] | Promising but limited |
| High-dose purified EPA in high-risk statin users | REDUCE-IT, 8,179 adults, 4 g a day icosapent ethyl: primary events 17.2% vs 22.0% (hazard ratio 0.75) [6] | Prescription drug trial only |
| Triglycerides | About 15% lower with EPA and DHA, dose-dependent [5] | Established |
| Stroke | Cochrane: little or no effect (risk ratio 1.02) [5] | Insufficient/no effect shown |
| Pregnancy outcomes | Cochrane (70 trials, 19,927 women): preterm birth under 37 weeks lower (13.4% vs 11.9%), early preterm under 34 weeks lower (4.6% vs 2.7%), low birthweight lower; prolonged pregnancy over 42 weeks higher (1.6% to 2.6%) [7] | Mixed to promising |
| Child brain development after pregnancy use | Cochrane: very few differences in cognition, IQ, vision or language [7]. NCCIH: limited evidence for cognition, insufficient for other outcomes [3] | Limited |
| Cognitive decline | A 2022 review of 33 studies suggests a protective effect in healthy people but none in people already diagnosed with Alzheimer's disease [3] | Promising but limited |
| Depression | A 2021 review of 35 studies (1,964 participants): effect, if any, may be too small to matter; low-quality evidence [3] | Insufficient |
| ADHD | A 2023 review of 36 studies in children found no evidence symptoms improve [3] | No benefit shown |
| Dry eye | DREAM trial: 3,000 mg a day for 12 months no better than placebo (OSDI difference -1.9 points, 95% CI -5.0 to 1.1) [8]. Small studies had suggested benefit [3] | Mixed, leaning no benefit |
| Age-related macular degeneration | AREDS2 (over 4,000 participants): adding EPA and DHA gave no additional benefit [3] | No benefit shown |
| Rheumatoid arthritis | Reviews: omega-3 foods may improve joint pain and swelling; one review judged evidence low [3] | Insufficient |
Notes on reading the table
- Heart disease. The REDUCE-IT result applies to a purified prescription EPA at 4 g a day in people already on statins with raised triglycerides; its labeling also reports more atrial fibrillation and bleeding than placebo. [6][1] Do not read it as proof that over-the-counter fish oil prevents heart attacks. Cochrane found effects did not differ by dose. [5]
- Pregnancy. The NHS says long-chain omega-3 from oily fish helps a baby's nervous system develop, and also advises avoiding fish liver oil supplements in pregnancy because of vitamin A. [9] US advice for pregnancy and breastfeeding is 8 to 12 ounces of lower-mercury seafood a week. [3] Talk to your maternity provider before any omega-3 product; see Pregnancy and breastfeeding and Prenatal and postnatal vitamins.
- Eyes. See also antioxidant evidence by use for AREDS2.
- Mental health. NCCIH notes depression can be serious and advises consulting a provider; supplements are not a substitute for care. [3]
Safety
Atrial fibrillation, bleeding and allergy cautions are on Omega-3 safety and interactions.Frequently asked questions
Is omega-3 good for the heart?
Eating fish is advised by the NHS for heart health; for supplements, Cochrane found little or no effect on overall death and cardiovascular events and a possible slight effect on coronary events. [9][5]
Does omega-3 help pregnancy?
A Cochrane review found fewer preterm births, but also more pregnancies lasting beyond 42 weeks. [7]
Does omega-3 help dry eyes?
The DREAM trial found no benefit over placebo at 3,000 mg a day. [8]
Is a prescription omega-3 better than a supplement?
They are different products tested for specific conditions. Do not swap one for the other. [3]
References
- FDA-approved prescribing information, Vascepa (icosapent ethyl), DailyMed. Read 2026-10-22.
- FDA-approved prescribing information, Lovaza (omega-3-acid ethyl esters), DailyMed. Read 2026-10-22.
- NCCIH, Omega-3 Supplements: What You Need To Know. Read 2026-10-22.
- Manson JE et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer (VITAL). N Engl J Med 2019. Read 2026-10-22.
- Abdelhamid AS et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2020. Read 2026-10-22.
- Bhatt DL et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia (REDUCE-IT). N Engl J Med 2019. Read 2026-10-22.
- Middleton P et al. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev 2018. Read 2026-10-22.
- Asbell PA et al. n-3 fatty acid supplementation for the treatment of dry eye disease (DREAM). N Engl J Med 2018. Read 2026-10-22.
- NHS, Fish and shellfish. Read 2026-10-22.
Education, not medical advice. This page is for general information. It does not diagnose or treat any condition and is not a substitute for care from a qualified health professional. Natural does not automatically mean safe. Ask a clinician or pharmacist before changing your care, especially if you take medication, are pregnant or breastfeeding, or have a health condition.